The Inaccuracy of the Mood Disorder Questionnaire for Bipolar Disorder in a Community Sample: From the “DYMERS” Construct Toward a New Instrument for Detecting Vulnerable Conditions
<b>Background/Objectives:</b> The Mood Disorder Questionnaire (MDQ) is a widely used tool for the early detection of Bipolar Disorder (BD), yet its diagnostic accuracy remains debated. In particular, the MDQ often yields false positives in individuals with anxiety, stress-related, or personality disorders, raising questions about its clinical utility. This study aimed primarily to evaluate the sensitivity, specificity, and predictive values of the MDQ in identifying BD within a large, community-based sample using structured clinical interviews. Additionally, we explored the construct of DYMERS (Dysregulation of Mood, Energy, and Social Rhythms Syndrome), a proposed condition characterized by mood instability, hyperactivation traits, and rhythm dysregulation among MDQ-positive individuals without a formal psychiatric diagnosis. <b>Methods:</b> A total of 4999 adults were surveyed across six Italian regions using a stratified random sampling method. Psychiatric diagnoses were established using DSM-IV-TR criteria via the Advanced Neuropsychiatric Tools and Assessment Schedule (ANTAS). The MDQ was administered face to face in its validated Italian version, with a positivity cut-off of ≥7. The MDQ exhibited low sensitivity and high specificity (0.962; 95% CI: 0.961-0.963). <b>Results:</b> Among 2337 analyzable cases, the MDQ showed high specificity (96.2%) but low sensitivity (42.9%) for BD, indicating limited effectiveness as a screening tool. In clinical terms, this implies that while MDQ-positive individuals are unlikely to be false positives, a substantial proportion of true BD cases are not identified. Notably, a significant subgroup of MDQ-positive individuals without psychiatric diagnoses displayed features consistent with DYMERS. <b>Conclusions:</b> Our findings confirm the limited screening value of the MDQ for BD in community samples. However, MDQ positivity may help identify a broader spectrum of mood and rhythm dysregulation not captured by current diagnostic systems. Future research should focus on validating DYMERS as a clinical entity and on developing targeted diagnostic instruments capable of capturing this emerging dimension of psychopathology.
Authors
- Elisa Cantone (ORCID: https://orcid.org/0009-0001-5049-4614)
- Giulia Cossu (ORCID: https://orcid.org/0000-0002-1245-016X)
- Massimo Tusconi (ORCID: https://orcid.org/0000-0002-9155-4740)
- Mauro Giovanni Carta (ORCID: https://orcid.org/0000-0003-0706-9687)
- Michela Atzeni (ORCID: https://orcid.org/0000-0002-0645-3006)
- Pedro José Fragoso Castilla (ORCID: https://orcid.org/0000-0002-3437-8664)
- Antonio Urban (ORCID: https://orcid.org/0009-0000-4948-8076)
- Shellsyn Giraldo Jaramillo (ORCID: https://orcid.org/0000-0003-4838-5993)
Institutions
- University of Cagliari (IT)
- Popular University of Cesar (CO)
Publication Details
- Journal
- Journal of Clinical Medicine
- Published
- 2025-04-27
- DOI
- https://doi.org/10.3390/jcm14093017
- Primary Topic
- Bipolar Disorder and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Agenzia Italiana del Farmaco, Ministero della Salute